Biomarkers and the potential for managing birth
Jim Posillico has a long academic and commercial pedigree in reproductive medicine, having spent time as a researcher at Harvard Medical School, Serono Laboratories, the Ares-Serono Group, InterMune Life Sciences and SAGE BioPharma. So when he learned of a metabolomics platform being developed at McGill University, he was quick to realize its applicability to a […]